The Board meeting is scheduled to be held on Wednesday, November 4, 2026. The agenda for the meeting includes:
- Consideration and approval of Un-Audited Standalone Financial Statements for the second quarter and half year ended September 30, 2026
- Consideration and approval of Un-Audited Consolidated Financial Statements for the second quarter and half year ended September 30, 2026
- Review of the Limited Review Report to be obtained from the Auditors
- Consideration of any other business matters
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct for prevention of Insider Trading, the trading window for dealing in the company's securities has been closed for all Designated Persons and their immediate relatives. The closure period is effective from October 1, 2026 until 48 hours after the consideration and declaration of the Financial Results (Un-Audited Standalone & Consolidated) for the second quarter and half year ended September 30, 2026 (both days inclusive). All designated persons and their immediate relatives are prohibited from dealing in the company's securities during this period.
The communication was digitally signed by Pooja Sandeep Thorave, Company Secretary & Compliance Officer (Membership No. A74339) on October 28, 2026 at 18:51:26 +05:30.